Blastic plasmacytoid dendritic cell neoplasm in a human T-cell lymphotropic virus type I (HTLV-1) carrier: A coincidental association?

European Journal of Dermatology

Volumn 23, Issue 2, 2013, Pages 250-251

  Uchida, Youhei ^a   Kawai, Kazuhiro ^a   Kubo, Hidemichi ^a   Takeda, Koichiro ^a   Shimokawa, Mitsuyoshi ^a   Yoshii, Noriko ^a   Kanekura, Takuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA DR ANTIGEN; LEUKOSIALIN; PREDNISONE; VINCRISTINE;

AGED; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CELL INFILTRATION; DERMIS; DISEASE ASSOCIATION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOPHENOTYPING; JAPANESE; LETTER; LEUKOCYTE COUNT; MALE; MEDICAL RECORD; MONONUCLEAR CELL; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; SUBCUTANEOUS TISSUE; TUMOR BIOPSY; TUMOR CELL; VIRUS CARRIER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARRIER STATE; DENDRITIC CELLS; FATAL OUTCOME; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; SKIN NEOPLASMS;

EID: 84877786176     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.1989     Document Type: Letter

References (5)

1. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press, 2008; 145-7.
2. Gurgen J, Hogan D, Muller K, Flowers J, Sexton W. CD4+/CD56+ TdT+ haematodermic neoplasm (previously called blastic natural killer cell lymphoma) in a patient with chronic human T-cell leukaemia virus type 1 infection: a previously unreported association. Br J Dermatol 2010; 162: 1395-7.
3. Goncalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 2010; 23: 577-89.
4. Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006. Pathol Int 2008; 58: 174-82.
5. Birmann BM, Mueller NE, Okayama A, et al. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I. J Med Virol 2006; 78: 847-52.